Thanks for choosing mmm-online.com Sign up for your FREE account now and join the thousands of other healthcare marketing professionals who rely on us for all the latest industry news and innovative ideas for direct and digital strategy. Simply fill out the fields below.

Keep me logged in Forgot your password?

Please wait...

Please wait...

Marc Iskowitz

 
 

Recent Articles

Novartis readying 2014 filing for lung cancer drug

June 04, 2013

Novartis is advancing its "breakthrough" lung cancer drug into Phase III based on promising Phase I data.
 

Novartis events draw DOJ lawsuits

May 31, 2013

The Justice Department has accused Novartis' US unit of offering opulent dinners and paying physicians as an enticement to prescribe its drugs.
 

Study finds link between innovation and revenue

May 31, 2013

A study, offers for the first time, according to researchers, empirical evidence of the link between a company's culture from a commercial-operations standpoint and revenue performance.
 

Consultants see big growth in India

May 31, 2013

Double-digit growth and a fragmented healthcare system in India have spurred consultancies and data firms, although experts say pricing for services varies widely.
 

BI, Lilly diabetes push keeps it simple

May 31, 2013

Boehringer Ingelheim and Eli Lilly rolled out a pre-launch med-ed campaign to differentiate their positioning in the SGLT2 diabetes drug class.
 

MSLs deployed in launch of Navidea diagnostic agent

May 31, 2013

Navidea Biopharmaceuticals is launching Lymphoseek, its diagnostic agent used to check for cancer spread, with medical affairs, promotional education and CME aimed at the nuclear medicine community.
 

Med Ed Report briefs: June 2013

May 31, 2013

News on the Australian Medical Association, Sanofi, GAME, Novartis and KnowledgePoint 360
 

PHCG plans a return to growth: CEO

May 31, 2013

Publicis Healthcare Communications Group (PHCG) is hoping to return to growth after a tame 2012, its CEO said.
 

GSK gets 2 cancer pills approved, but a deeper question is left unanswered

May 30, 2013

GSK's newest cancer approvals highlight a problem that stalks progress with personalized medicines.
 

Merck's Heller on how to get more women into the C-suite

May 14, 2013

Bridgette Heller, Merck EVP and president of its consumer care division, adjured life-sci managers to enable women to unleash the full power of their knowledge and ideas to drive growth in the business.
 
« Previous
  

Web Exclusive

What NOT to say to an MS Patient

Dorothy Wetzel June 07, 2013

It is often hard to find the right words when talking to a patient, friend or family member with MS. Even with training and awareness of the disease, we often blurt out something we think is innocuous only to find out later that we have deeply offended. The Health Activists that Extrovertic spoke to had some suggestions for having positive conversations with someone with MS.
 

2013 Hall of Fame Inductees

An entertaining look at the extraordinary lives and careers of the Medical Advertising Hall of Fame's 2013 inductees: Peter Frishauf, Dorothy Philips and David Labson. Clips produced by JUICE Pharma. 

Slideshows

MAHF 2013: Honors Class

A gallery of images from the 2013 Medical Advertising Hall of Fame induction dinner
 
Popular Topics
Acquisition Advertising App Cardiovascular Clinical Trial Diabetes FDA Generic Generic Drugs Health Affairs Healthcare Reform Journal Articles Layoffs Mobile Obesity Oncology OPDP Patent Cliff Patents Personalized Medicine Pipeline Research & Development Rheumatology Social Media Women's Health

Topics

Consumer
Continuing Medical Education (CME)
Digital
Direct to Consumer
Direct to Patient
Downsize
Education & Awareness
FDA
Label
Legal
Online
Over the Counter
Promotion
Public Relations
Sales Force
Trend

Sectors

Agency
Biotech
Government
Media
Pharmaceutical
Suppliers & Vendors

Verticals

Business
Marketing & Communications
Regulatory
Research & Development

Events

Awards

Archives

Issue Archive
Sitemap
 

© 2013 Haymarket Media, Inc.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions